HIV integration site distributions in resting and activated CD4+ T cells infected in culture
暂无分享,去创建一个
Nirav Malani | F. Bushman | C. Berry | Nirav Malani | Troy L. Brady | Frederic Bushman | Luis M Agosto | L. Agosto | U. O’Doherty | Troy Brady | Charles C Berry | Una O'Doherty
[1] F. Bushman,et al. Retroviral DNA integration: HIV and the role of LEDGF/p75. , 2006, Trends in genetics : TIG.
[2] Paul Shinn,et al. Integration Targeting by Avian Sarcoma-Leukosis Virus and Human Immunodeficiency Virus in the Chicken Genome , 2005, Journal of Virology.
[3] James R. Knight,et al. Genome sequencing in microfabricated high-density picolitre reactors , 2005, Nature.
[4] J. Griffith,et al. Sequence analysis of the human DNA flanking sites of human immunodeficiency virus type 1 integration , 1996, Journal of virology.
[5] A. Haase,et al. Determination of simian immunodeficiency virus production by infected activated and resting cells , 2007, AIDS.
[6] C. June,et al. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] F. Bushman,et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.
[8] U. O’Doherty. Mechanisms of human immunodeficiency virus‐1 latency , 2005, Transfusion.
[9] R. Siliciano,et al. Resting CD4+ T Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals Carry Integrated HIV-1 Genomes within Actively Transcribed Host Genes , 2004, Journal of Virology.
[10] R. Siliciano,et al. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. , 2008, Cell host & microbe.
[11] Paul Shinn,et al. HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[12] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Siliciano,et al. The challenge of viral reservoirs in HIV-1 infection. , 2002, Annual review of medicine.
[14] H. Gendelman,et al. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone , 1986, Journal of virology.
[15] A. Engelman,et al. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. , 2007, Genes & development.
[16] C. June,et al. Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity. , 2001, The Journal of experimental medicine.
[17] M. Malim,et al. Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding , 2000, Journal of Virology.
[18] Sean D. Taverna,et al. How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers , 2007, Nature Structural &Molecular Biology.
[19] Dustin E. Schones,et al. Dynamic Regulation of Nucleosome Positioning in the Human Genome , 2008, Cell.
[20] S. Burgess,et al. Weak Palindromic Consensus Sequences Are a Common Feature Found at the Integration Target Sites of Many Retroviruses , 2005, Journal of Virology.
[21] F. Bushman,et al. Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.
[22] F. Bushman,et al. Chromosome Structure and Human Immunodeficiency Virus Type 1 cDNA Integration: Centromeric Alphoid Repeats Are a Disfavored Target , 1998, Journal of Virology.
[23] Frederic D. Bushman,et al. A quantitative assay for HIV DNA integration in vivo , 2001, Nature Medicine.
[24] H. Varmus,et al. Simian virus 40 minichromosomes as targets for retroviral integration in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Dai,et al. HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. , 2007, Virology.
[26] Irene K. Moore,et al. A genomic code for nucleosome positioning , 2006, Nature.
[27] Paul Shinn,et al. Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection , 2006, PLoS pathogens.
[28] Dustin E. Schones,et al. High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.
[29] M. Malim,et al. A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration , 2002, Journal of Virology.
[30] F. Bushman,et al. DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations , 2007, Nucleic acids research.
[31] John M. Coffin,et al. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[33] J. Zack,et al. Immediate Activation Fails To Rescue Efficient Human Immunodeficiency Virus Replication in Quiescent CD4+ T Cells , 2007, Journal of Virology.
[34] J. Dai,et al. Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4+ T Cells in the Absence of Activating Stimuli , 2005, Journal of Virology.
[35] C. June,et al. Addition of Deoxynucleosides Enhances Human Immunodeficiency Virus Type 1 Integration and 2LTR Formation in Resting CD4+ T Cells , 2007, Journal of Virology.
[36] F. Bushman,et al. DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer , 2008, Nucleic acids research.
[37] F. Bushman,et al. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. , 2007, Genome research.
[38] F. Bushman,et al. Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. , 2006, Human gene therapy.
[39] A. Jordan,et al. The site of HIV‐1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation , 2001, The EMBO journal.
[40] F. Bushman,et al. The influence of DNA and nucleosome structure on integration events directed by HIV integrase. , 1994, The Journal of biological chemistry.
[41] Paul Shinn,et al. Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[42] F. Bushman,et al. Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[43] Jared E. Toettcher,et al. Stochastic Gene Expression in a Lentiviral Positive-Feedback Loop: HIV-1 Tat Fluctuations Drive Phenotypic Diversity , 2005, Cell.
[44] Sridhar Hannenhalli,et al. Genome-wide analysis of retroviral DNA integration , 2005, Nature Reviews Microbiology.
[45] F. Bushman,et al. Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting , 2007, PloS one.
[46] Shawn M. Burgess,et al. Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.
[47] Mary K. Lewinski,et al. Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription , 2005, Journal of Virology.
[48] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[49] Marcela V Maus,et al. A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes. , 2002, Clinical immunology.
[50] Tina Lenasi,et al. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. , 2008, Cell host & microbe.
[51] R. Siliciano,et al. Experimental approaches to the study of HIV-1 latency , 2007, Nature Reviews Microbiology.
[52] Paul Shinn,et al. HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.
[53] C. June,et al. Lack of Coreceptor Allows Survival of Chronically Stimulated Double-Negative α/β T Cells , 2001, The Journal of Experimental Medicine.
[54] Sridhar Hannenhalli,et al. Selection of Target Sites for Mobile DNA Integration in the Human Genome , 2006, PLoS Comput. Biol..
[55] Paul Shinn,et al. A role for LEDGF/p75 in targeting HIV DNA integration , 2005, Nature Medicine.